The investigation began with a deceptively simple question: does flower color correlate with leaf chemistry? Understanding phytochemical variability within a species matters because it shapes how researchers and industries select plant material for natural product discovery. If two visually distinct forms of the same tree accumulate different suites of phenolic compounds, then any pharmacological or food-industry application of E. sideroxylon could depend heavily on which form is harvested, and even on which solvent is used during extraction. The team therefore designed a systematic comparison, extracting leaf material from each form with both methanol and ethanol and then subjecting the resulting extracts to a battery of quantitative and analytical tests.

The quantitative results were striking. Methanolic extracts consistently outperformed their ethanolic counterparts in total secondary metabolite content, and the red-flowered form stood out with a total phenolic content reaching 528.40 milligrams of gallic acid equivalents per gram of dry weight. Condensed tannins were also abundant, peaking at 334.60 milligrams of tannic acid equivalents per gram of dry weight, while flavonoid contents ranged between 60.40 and 64.60 milligrams per gram of dry weight. These figures place E. sideroxylon among the more phenolic-rich eucalypts examined in the broader literature, and they underscore why solvent choice is such a critical variable: methanol, being more polar, appears to draw a richer load of phenolics out of the leaf matrix than ethanol does.

To move beyond bulk measurements, the researchers turned to high-performance liquid chromatography coupled with diode-array detection, a technique that separates individual compounds and records their characteristic light absorption spectra. This HPLC-DAD profiling allowed the tentative annotation of seventeen phenolic compounds, whose relative abundances shifted according to both the extraction solvent and the flower-color form. Rutin, myricetin and diosmin emerged as among the most abundant putatively assigned compounds in the methanolic extract of the white-flowered form, whereas morin hydrate was particularly prominent in the ethanolic extract of the red-flowered form. Such differences are chemically meaningful: rutin and myricetin are flavonoids with well-documented antioxidant behavior, while morin hydrate has attracted attention for its wide-ranging pharmacological potential.

Complementing the chromatography, the team applied attenuated total reflectance Fourier-transform infrared spectroscopy, or ATR-FTIR, a rapid fingerprinting method that identifies functional groups within a sample by measuring how its molecular bonds absorb infrared light. The spectra revealed absorption features consistent with phenolic compounds, including signals attributable to hydroxyl groups and aromatic ring structures, and the spectroscopic patterns supported the trends observed chromatographically. This dual confirmation matters because it demonstrates that two independent analytical windows, one separation-based and one vibration-based, tell a coherent story about the chemical composition of the extracts, lending weight to the tentative compound assignments made by HPLC-DAD alone.

Biological testing followed, and the extracts delivered a series of concentration-dependent effects. In the DPPH radical scavenging assay, a standard measure of antioxidant capacity, all four extracts neutralized free radicals in a dose-dependent fashion, with the methanolic extracts again leading the pack. The white-flowered methanolic extract achieved an IC50 of 109.30 micrograms per milliliter, meaning that concentration sufficed to quench half of the radicals present, while the red-flowered methanolic extract required 151.10 micrograms per milliliter. Lower IC50 values indicate stronger antioxidant activity, so the white-flowered form’s methanolic extract was the most potent radical scavenger in this comparison, an outcome consistent with its flavonoid-rich profile.

Antimicrobial screening added another dimension. The extracts inhibited microbial growth in a concentration-dependent manner, with the largest inhibition zones measuring 15 millimeters against the Gram-positive bacterium Bacillus subtilis and 18 millimeters against the yeast Candida albicans. The authors are careful to frame these results as initial screening evidence rather than definitive antimicrobial potency data, but the pattern aligns with a substantial body of literature showing that plant phenolics, particularly flavonoids, can disrupt microbial membranes and interfere with microbial metabolism. The activity against Candida albicans is especially noteworthy given the clinical challenge posed by fungal infections and the ongoing search for plant-derived antifungal leads.

Perhaps the most pharmacologically intriguing results concerned enzyme inhibition and membrane protection. The extracts suppressed alpha-amylase, the digestive enzyme that breaks down starch into sugars, with the strongest preparation achieving 74.36 percent inhibition and an IC50 of 3.33 milligrams per milliliter. Kinetic analysis suggested an apparent competitive mode of inhibition under the experimental conditions, meaning the extracts’ constituents appear to compete with starch for the enzyme’s active site, a mechanism directly relevant to managing post-meal blood glucose spikes. However, the authors caution that this inhibition pattern requires validation through nonlinear kinetic modeling and independent determination of inhibition constants before firm mechanistic conclusions can be drawn. On the anti-inflammatory front, the extracts stabilized biological membranes, protecting up to 42.02 percent of red blood cells against heat-induced hemolysis, with methanolic extracts generally outperforming ethanolic ones. Because membrane stabilization is considered a plausible in vitro proxy for anti-inflammatory action, this result opens a tentative window onto the extracts’ therapeutic potential.

The researchers are equally candid about the limits of their work, and that transparency is itself scientifically valuable. Only one biological specimen from each flower-color variant was sampled, so the findings describe the particular extracts examined rather than population-level differences between red- and white-flowered E. sideroxylon as a whole. Tree age, season, soil, climate and local growing conditions can all influence phenolic accumulation, and a single tree per form cannot disentangle genetic flower-color effects from environmental noise. The team explicitly recommends broader sampling and complementary analytical approaches, including more rigorous enzyme kinetics, to test whether the observed chemical and biological patterns hold up across populations and to establish their biological significance.

Even with those caveats, the study adds a compelling chapter to the natural products literature surrounding eucalypts, a genus already celebrated for essential oils, polyphenols and antimicrobial compounds. It demonstrates, with technical rigor, that a visible trait like flower color can accompany measurable shifts in leaf chemistry and bioactivity, and it highlights how extraction solvent acts as a powerful lever on both composition and function. For researchers hunting new antioxidants, antifungal agents or alpha-amylase inhibitors, the message is that E. sideroxylon deserves closer attention, and that the red and white forms may offer subtly different chemical toolkits. For the wider public, it is a reminder that the chemistry of a familiar street tree can be far richer, and far more variable, than its appearance suggests.

Subject of Research: Comparative phytochemical profiling and biological activities of red- and white-flowered forms of Eucalyptus sideroxylon

Article Title: Comparative phytochemical profiling and biological activities of red- and white-flowered forms of Eucalyptus sideroxylon (Myrtaceae)

Article References: Comparative phytochemical profiling and biological activities of red- and white-flowered forms of Eucalyptus sideroxylon (Myrtaceae). (n.d.). https://doi.org/10.1007/s44473-026-00273-8

Image Credits: AI Generated

DOI: 10.1007/s44473-026-00273-8

Keywords: Eucalyptus sideroxylon, phytochemical profiling, phenolic compounds, flavonoids, antioxidant activity, antimicrobial activity, alpha-amylase inhibition, anti-inflammatory activity, HPLC-DAD, ATR-FTIR spectroscopy, solvent extraction, Myrtaceae

The team was interested in two particular lichen secondary metabolites: usnic acid, a yellow pigment famous among natural products chemists, and atranorin, a depside compound common in many lichen thalli. Both have documented biological activities, but the researchers set out with a more nuanced question. If individual compounds can kill bacteria on their own, does the full chemical cocktail found in a crude lichen extract do the job even better? The answer from their experiments appears to be a cautious yes, with evidence suggesting that mixtures of metabolites may act synergistically rather than as isolated single agents.

To get a reliable picture of what was inside each extract, the scientists used high-performance liquid chromatography coupled with a diode array detector, an analytical technique that separates complex mixtures and identifies compounds based on how they absorb ultraviolet light. After extracting the lichen material with a one-to-one mixture of methanol and acetone, they quantified usnic acid and atranorin across all eight species. The concentrations ranged from a modest 0.024 percent up to 1.2 percent for usnic acid, and from 0.018 to 0.46 percent for atranorin. These numbers matter because they allow direct comparison between the chemical composition of each species and its measured biological effect, transforming what could have been a simple screening exercise into a structured structure-activity investigation.

The antimicrobial results are where the study becomes genuinely striking. The researchers tested their extracts against four strains of Staphylococcus aureus, the notorious bacterium responsible for everything from skin infections to life-threatening sepsis and a World Health Organization priority pathogen. Using broth microdilution assays to determine the minimum inhibitory concentration, they found that all eight lichen extracts suppressed bacterial growth at concentrations between 0.1 and 0.35 milligrams per milliliter. That places the crude extracts in the same potency range as gentamicin, a standard clinical antibiotic tested at 0.1 milligrams per milliliter in the same assays. Pure usnic acid was even stronger at 0.02 milligrams per milliliter, but the fact that unfractionated extracts approached clinical-antibiotic territory is remarkable for unmodified natural material.

Crucially, the team went beyond simply asking whether the extracts stopped growth. They determined the minimum bactericidal concentration for each extract, the dose at which bacteria are actually killed rather than merely inhibited. When the ratio of the bactericidal concentration to the inhibitory concentration falls below four, microbiologists classify a substance as genuinely bactericidal. Every extract in the study met that criterion against the staphylococcal strains, meaning these lichen compounds do not just hold bacteria in check but destroy them. The same logic applied to the antifungal experiments, where minimum fungicidal concentration to minimum inhibitory concentration ratios also fell below four against the tested Candida strains.

That antifungal activity, while real, was more modest. Extracts inhibited Candida growth at concentrations between 0.4 and 1.0 milligrams per milliliter, a range the authors characterize as moderate. Candida species are among the most common fungal pathogens of humans, and rising resistance to existing antifungal drugs has made the search for new chemical scaffolds increasingly urgent. While a lichen extract would need considerable development before it could inform any clinical antifungal, the finding that these same extracts carry fungicidal activity alongside potent antibacterial effects makes them chemically richer candidates for follow-up work than many single-purpose natural products.

The study also examined antioxidant capacity, another dimension of lichen chemistry that has attracted attention for its possible health relevance. Using three complementary assays, the researchers measured the ability of the extracts to neutralize synthetic radicals and reduce iron. In the DPPH radical scavenging assay, effective concentrations fell between 1364 and 2461 micrograms per milliliter. The ABTS decolorization assay yielded values from 11.5 to 15.9 milligrams of Trolox equivalents per gram, while the ferric reducing antioxidant power assay produced readings between 169 and 719.79 micromoles of iron equivalents per gram. Total phenolic content, measured with the Folin-Ciocalteu method, ranged from 11.34 to 332.15 micrograms of gallic acid equivalents per gram, a wide spread that highlights just how chemically different these eight co-occurring species can be.

Among the species tested, one stood out in the antioxidant profiling: the extract of Alectoria ochroleuca showed the second-highest total phenolic content and a moderate antioxidant performance across the assays. Phenolic compounds are well-established antioxidants because their molecular structures can donate electrons or hydrogen atoms to neutralize reactive oxygen species, the unstable molecules implicated in cellular damage, aging, and numerous diseases. In lichens, which endure intense ultraviolet radiation and desiccation on exposed mountain surfaces, an arsenal of protective phenolics makes evolutionary sense. Atranorin and usnic acid themselves contribute to this chemical sunscreen and defense system, which is precisely why lichens have become such attractive targets for pharmacological screening.

The authors are careful about interpretation, and appropriately so. Because pure usnic acid outperformed the crude extracts against Staphylococcus aureus, and because the biological effects did not map neatly onto the concentrations of any single measured compound, the data point toward synergy among metabolites. In natural products research, synergy is both an opportunity and a complication. It can mean that combinations of molecules achieve effects no individual component could, potentially through multiple mechanisms of attack that also make resistance harder to develop. But it also means that isolating a single magic molecule may never fully reproduce the activity of the whole extract, complicating standardization and drug development. The study’s conclusion emphasizes that future work isolating individual metabolites and evaluating their bioactivity in vivo will be needed to confirm the pharmacological relevance of these extracts.

What makes this research resonate beyond the laboratory is its setting. Lichens are among the hardiest organisms on the planet, thriving on bare rock, tree bark, and harsh Andean slopes where almost nothing else grows, and their chemical inventories remain astonishingly underexplored. Studies like this one, combining rigorous chromatographic quantification with standardized susceptibility testing and antioxidant assays, provide exactly the kind of reproducible baseline data needed to turn folklore about healing lichens into testable pharmacology. With antibiotic resistance climbing worldwide and the pipeline of new drugs running thin, the humble organisms carpeting a Peruvian mountainside may hold molecular lessons that modern medicine has barely begun to read. The next chapter will depend on whether the synergistic activity seen in these crude extracts survives the journey from the extraction flask through animal studies and, eventually, toward the clinic.

Subject of Research: Antimicrobial and antioxidant activities of eight Peruvian lichen species analyzed by HPLC-DAD quantification of usnic acid and atranorin.

Article Title: HPLC-DAD quantification of usnic acid and atranorin and evaluation of antibacterial and antifungal activities in eight peruvian lichens

Article References: Carrasco, F., Hernández, W., Guerrero, M., Rojas, R., Tamariz-Angeles, C., Olivera-Gonzales, P., Briceño-Luna, V., Solis, E. C., Raposo, C., Rodilla, J. M., & Silva, L. (2026). HPLC-DAD quantification of usnic acid and atranorin and evaluation of antibacterial and antifungal activities in eight peruvian lichens. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05599-6

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05599-6

Keywords: lichens, usnic acid, atranorin, HPLC-DAD, antimicrobial activity, antioxidant, Peru, Staphylococcus aureus, Candida, natural products, secondary metabolites, synergy